Fundamentally, you are correct for the time being. Canadian MJ overpaid for assets, had significant Goodwill writeoffs, and suffered a glut of surplus supply resulting in smaller net profits.
That being said, CGC was forced to right size production to better meet demand
CGC has an opportunity to enter US market, which is much much larger than Canadian market. If/when US legalizes mj and FDA reschedules mj CGC will be in the mix.
In addition, CGC is anticipating that they will be profitable by second half of 2022
Is that a ways away? Yes. Has PPS gotten ahead of current fundamentals? Yes, but CGC filled gap last Thursday